Thomas Jefferson University’s Center for Medical Cannabis Education & Research and Temple University’s Lewis Katz School of Medicine will present an accredited continuing medical education course at Greenhouse Ventures upcoming conference in Philadelphia.
“Innovation in the Cannabis Industry: Future Outlook,” takes place Dec. 9 at the Chemical Heritage Foundation. The event is the second industry conference from Philadelphia based Greenhouse Ventures – a business accelerator specific for ancillary startups in the cannabis and industrial hemp industries.
Future Outlook will include panel discussions with over 15 professionals with backgrounds in finance, technology, government, and medical research. With the new Trump Administration, Sen. Jeff Sessions nominated as Attorney General, and 8 states having just voted to legalize medical and/or recreational use of cannabis, 2017 is set to be a historic year for the cannabis industry.
The CME course presented by the hospitals, in association with the Sidney Kimmel Medical College at Thomas Jefferson University, will last one hour and provides credit toward doctors required annual continuing medical education. Only 30 seats are available. It runs from 8 to 9 a.m. Dec. 9, before the conference opens to the general public. It takes place before the general conference.
Charles V. Pollack, M.D., Director of Thomas Jefferson University’s Center for Medical Cannabis Education & Research, is excited to be part of the presentation. “Given the expanding range of interest in fact-based understanding of medical cannabis and the science behind it, we look forward to supporting the continuing education of all interested stakeholders,” Pollack said.
“Pennsylvania, Philadelphia in particular, has the unique opportunity to position itself as the medical research hub for the cannabis industry”, said Tyler Dautrich, co-founder of Greenhouse Ventures.